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ABSTRACT
Objective: To assess the clinical relevance and
newsworthiness of the UK National Institute for Health
Research (NIHR) Health Technology Assessment (HTA)
Programme funded reports.
Study design: Retrospective cohort study.
Setting: The cohort included 311 NIHR HTA
Programme funded reports publishing in HTA in the
period 1 January 2007–31 December 2012. The
McMaster Online Rating of Evidence (MORE) system
independently identified the clinical relevance and
newsworthiness of NIHR HTA publications and non-
NIHR HTA publications. The MORE system involves
over 4000 physicians rating publications on a scale of
relevance (the extent to which articles are relevant to
practice) and a scale of newsworthiness (the extent to
which articles contain news or something clinicians are
unlikely to know).
Main outcome measures: The proportion of reports
published in HTA meeting MORE inclusion criteria and
mean average relevance and newsworthiness ratings
were calculated and compared with publications from
the same studies publishing outside HTA and non-
NIHR HTA funded publications.
Results: 286/311 (92.0%) of NIHR HTA reports were
assessed by MORE, of which 192 (67.1%) passed
MORE criteria. The average clinical relevance rating for
NIHR HTA reports was 5.48, statistically higher than the
5.32 rating for non-NIHR HTA publications (mean
difference=0.16, 95% CI 0.04 to 0.29, p=0.01). Average
newsworthiness ratings were similar between NIHR HTA
reports and non-NIHR HTA publications (4.75 and 4.70,
respectively; mean difference=0.05, 95% CI −0.18 to
0.07, p=0.402). NIHR HTA-funded original research
reports were statistically higher for newsworthiness
than reviews (5.05 compared with 4.64) (mean
difference=0.41, 95% CI 0.18 to 0.64, p=0.001).
Conclusions: Funding research of clinical relevance is
important in maximising the value of research
investment. The NIHR HTA Programme is successful in
funding projects that generate outputs of clinical
relevance.
INTRODUCTION
Commissioning new research in areas of
high clinical relevance is an important part
of minimising research waste. Chalmers and
Glasziou1 in their paper on avoidable waste
in research argue that selecting unimportant
research questions is a major contributor to
wasted research funds. Studies have shown,
for example, that only moderate correlations
exist between publicly funded research and
burden of disease.2 Similarly, research con-
ducted on patient or clinician research prior-
ities has revealed potential mismatches
between clinical priorities and funded
research. Tallon et al,3 for example, exam-
ined the research priorities of patients with
osteoarthritis of the knee and their clinicians
and reported that their priorities differed
from randomised controlled trials, which
were typically focused on drug evaluations.
One proxy measure of the clinical rele-
vance of funded research is the assessment
of the relevance of the ﬁnal publication.
McMaster University has established a rigor-
ous approach to assessing the clinical rele-
vance and newsworthiness of outputs from
health research.4 The McMaster approach
involves selecting relevant papers from 120
high-impact journals selected on the basis of
suggestions from librarians, clinicians, editors
Strengths and limitations of this study
▪ The strength of this study is that a rigorous,
extensive and independent approach to asses-
sing the clinical relevance and newsworthiness
of funded research provided by MORE was
applied to the National Institute for Health
Research (NIHR) Health Technology Assessment
(HTA) reports.
▪ A limitation of this study was that the data were
reliant on funded research teams self-reporting
their publications. It is most likely that the
number of publications is under-reported from
NIHR HTA-funded studies.
▪ Raters contributing to McMaster Online Rating of
Evidence are voluntary and are therefore likely to
be interested in evidence-based medicine.
Therefore, they may not be representative of all
physicians.
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and editorial staff, Science Citations Index impact
factors, a systematic examination of journal contents and
an ongoing assessment of the number of articles that
meet inclusion criteria of quality. Articles from selected
journals are assessed by trained staff using inclusion cri-
teria on methodological quality and whether the article
has at least one clinically important outcome.4 Articles
passing these criteria are entered onto the Critical
Appraisal Process (CAP) system before being transferred
to the McMaster Online Rating of Evidence (MORE)
system, which has in excess of 4000 physician raters in
over 60 physician disciplines. Articles are sent to at least
four raters for each matched discipline/specialty, who
rate papers on two seven-point scales (seven—highest
score; table 1). The ﬁrst scale of relevance assesses the
extent to which the article is relevant to practice. If rele-
vance is rated three or above, a second scale is used
assessing the extent to which the article contains news
or something that clinicians are unlikely to know.
Articles that average three or above for a discipline are
then transferred to a Premium LiteratUre Service
(PLUS) database, and are then used to alert subscribers
via Evidence Updates, ACP JournalWise and other
current awareness services. Ratings, which are collected
at the time of journal article publication, have been
shown to be predictive of subsequent citation counts.5
The McMaster approach to assessing clinical relevance
and newsworthiness has enabled interesting comparisons
to be made between research and publication types.
One study explored the relevance and newsworthiness
of high-quality original articles and systematic reviews
from over 110 clinical journals and the Cochrane
Database of Systematic Reviews.6 The study revealed that
systematic reviews had a signiﬁcantly higher rating for
relevance than original articles, but a signiﬁcantly lower
rating for newsworthiness.6 In addition, clinicians
accessed reviews more frequently than original articles.6
The National Institute for Health Research (NIHR)
Health Technology Assessment (HTA) Programme was
established in 1993 to commission research that is useful
to clinical practice and NHS decision-makers.7 Since its
inception, signiﬁcant effort has been made to identify and
prioritise important topics from a range of stakeholders
and to assess applications on the basis of scientiﬁc merit,
feasibility and value for money. In the 10 years since 2002,
98% of NIHR HTA-funded studies have completed with a
ﬁnal report in the HTA Journal8 and the journal has always
been included in the McMaster’s top 120 journals. The
reports (also referred to as monographs) are peer
reviewed, are available freely in the public domain and
contain a full record of the study. Unlike typical peer
reviewed journals, the HTA Journal has a large word guide
of approximately 50 000 words and unlimited appendices,
thus enabling more detail to be included than standard
peer review publications. Given the emphasis on identify-
ing and commissioning important topics and having easily
accessible and usable ﬁnal reports, this study aimed to
assess the clinical relevance and newsworthiness of NIHR
HTA reports compared with non-NIHR HTA publications
assessed by the MORE process.
METHODS
Selection of reports and publications
Of 314 studies published as full reports in the NIHR
HTA Journal in the period 1 January 2007−31
December 2012, 311 were selected for the study. Three
NIHR HTA reports were excluded from the analysis as
they were updates of earlier Cochrane reviews, and
therefore ratings of relevance and newsworthiness of
these reports were not based on the ﬁrst time these
reviews were made available to the public. PubMed
Identiﬁcation numbers were identiﬁed for each report,
which were obtained by hand searching PubMed.
Table 1 The McMaster Online Rating of Evidence (MORE) criteria for clinical relevance and newsworthiness
Score
Relevance to clinical practice in your
discipline—criteria
Newsworthiness to clinical practice in your discipline—
criteria
No score Beyond my personal area of expertise but
may be of interest to my discipline
I don’t know if this is newsworthy
7 Directly and highly relevant Useful information; most practitioners in my discipline definitely do
not know this (unless they have read this article)
6 Definitely relevant Useful information; most practitioners in my discipline probably do
not know this
5 Probably relevant Useful information; most practitioners in my discipline possibly do
not know this
4 Possibly relevant: likely of indirect or
peripheral relevance at best
Useful information; most practitioners in my discipline possibly
already know this
3 Possibly not relevant Useful information; most practitioners in my discipline probably
already know this
2 Probably not relevant: content only remotely
related
It probably does not matter whether they know this or not
1 Definitely not relevant: completely unrelated
content area
Not of direct clinical interest
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Publications arising from NIHR HTA-funded studies
publishing outside the HTA Journal in the period 1
January 2007−31 December 2012 were identiﬁed using
research management databases maintained by the
NIHR HTA Programme. Again, PubMed Identiﬁcation
numbers were obtained for each publication and these
data were used to remove NIHR HTA Programme-
funded research outputs from the database of articles
from the 120 selected journals that had passed CAP and
MORE criteria. A subgroup was identiﬁed for publica-
tions from studies reporting in the HTA Journal in the
period 2007–2012. This enabled a direct comparison
between reports in the HTA Journal and related publica-
tions from the same studies publishing outside the
Journal.
All data were assessed by a second researcher to
ensure that there were no duplications and that the pub-
lication and PubMed details were accurate. Data were
held in an Excel spreadsheet, which was given to
McMaster. The PubMed identiﬁcation numbers were
used to determine which articles were reviewed for and
passed the CAP process, and then to automatically
retrieve relevance and newsworthiness ratings from the
MORE database.
Units of analysis, hypotheses and statistical analyses
Three datasets were generated that formed the basis of the
analysis
A. NIHR HTA-funded studies publishing as full reports
in HTA in the period 1 January 2007–31 December
2012.
B. Publications in the period 1 January 2007–31
December 2012 from NIHR HTA-funded studies pub-
lishing outside HTA for those studies included in cat-
egory A above.
C. Publications from non-NIHR HTA-funded publica-
tions publishing in the period 1 January 2007–31
December 2012 from Journals included by McMaster
and passing CAP and MORE criteria.
Two principal hypotheses were tested
Hypothesis 1: Reports published in HTA have a higher
MORE clinical relevance and newsworthiness rating than
non-NIHR HTA publications. The rationale for this
hypothesis is that the NIHR HTA Programme aims to
ensure that funded research responds to clinical need
and has a rigorous process of identiﬁcation and prioritisa-
tion to reﬂect clinical priorities. We therefore wanted to
see if outputs from NIHR HTA funded research rated
higher in terms of clinical relevance and newsworthiness.
Hypothesis 2: Reports published in HTA have a lower
mean average MORE clinical relevance and newsworthi-
ness rating than publications from the same research
published outside the HTA Journal. The rationale for
this is that funded research teams are encouraged to
publish outside the HTA Journal, and therefore prior
publication may affect the relevance ratings of the
report if study ﬁndings are already in the public
domain. Previous research had reported that some
journal publications did precede publication in the HTA
Journal, although it was recognised that this was not
always the case and that for some studies, non-HTA
Journal publications occurred well after the end of the
project.9
Subgroup analysis was undertaken for hypotheses
exploring differences in clinical relevance and news-
worthiness ratings between original studies and review
articles. Original studies are deﬁned as ‘Any full text
article in which the authors report ﬁrst-hand observa-
tions’. Review articles are deﬁned as ‘any full text article
that was bannered “review, overview, or meta-analysis” in
the title or in a section heading, or it was indicated in
the text of the article that the intention was to review,
summarise, or highlight the literature on a particular
topic’.10 Previous research had identiﬁed that original
research studies were more newsworthy but less clinically
relevant than review articles.6 We wished to explore
whether this was also the case for NIHR HTA reports.
As discussed elsewhere,6 article ratings were treated as
continuous variables and were analysed by calculating
mean averages and proportions and comparing CIs of
computed results. SPSS V.20 was used for all analyses;
differences were compared using p values.
RESULTS
Proportions of reports and publications meeting CAP
and MORE criteria
Of 311 NIHR HTA reports published in the period
2007–2012, 286 (92%) were included in the initial CAP
assessment. Twenty-ﬁve reports were not included in the
analysis due to a technical error, 18 of which were pub-
lished in the period 20 February 2012–8 May 2012. Of
the 274 HTA publications publishing outside the HTA
Journal in the period 2007—2012, 118 (43.1%) were
assessed for CAP. Non-inclusion of NIHR HTA-funded
publications was due to the publications appearing in
journals not included in the 120 journals assessed by
McMaster.
Table 2 reveals that 67.8% (n=194) of NIHR HTA
reports passed initial screening criteria of methodo-
logical rigour and relevance, compared with 57.6%
(n=68) of other NIHR HTA-funded publications and
10.6% (n=20 194) of non-NIHR HTA publications
included on the McMaster database. A total of 67.1%
(n=192) of NIHR HTA reports passed MORE inclusion
(ie, scoring ≥ 3/7 for both relevance and newsworthiness
for at least one discipline), compared with 57.6% (n=68)
of other NIHR HTA-funded publications and 10.5%
(n=19 921) of non-NIHR HTA-funded publications.
Clinical relevance ratings in MORE
NIHR HTA reports had an average mean relevance
rating of 5.48 (95% CI 5.36 to 5.59), which was higher
than the mean relevance rating for non-NIHR HTA pub-
lications passing CAP and MORE criteria, which was
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5.32 (95% CI 5.31 to 5.33) (mean difference=0.16, 95%
CI 0.04 to 0.29, p=0.01; table 3). NIHR HTA-funded
publications publishing outside HTA had an average
mean relevance rating of 5.59 (95% CI 5.42 to 5.75),
which was slightly higher than the rating for NIHR HTA
reports (mean difference=0.11, 95% CI −0.10 to 0.32,
p=0.419).
The mean relevance rating of NIHR HTA original
research reports was 5.54 (95% CI 5.34 to 5.74), which
was higher than non—NIHR HTA original research pub-
lications, which had a mean relevance rating of 5.27
(95% CI 5.26 to 5.29) (mean difference=0.27, 95% CI
0.03 to 0.51, p=0.03; table 4). The mean relevance rating
of NIHR HTA original research reports was similar to
publications from the same studies publishing outside
the HTA Journal, which had a mean average relevance
rating of 5.57 (95% CI 5.36 to 5.78) (mean differ-
ence=0.03, 95% CI −0.32 to 0.26, p=0.875; table 4).
The mean relevance rating of NIHR HTA-funded
review reports was 5.46 (95% CI 5.32 to 5.60), which was
similar to that for non-NIHR HTA-funded publications,
which had a mean relevance rating of 5.41 (95% CI 5.39
to 5.43) (mean difference=0.05, 95% CI −0.09 to 0.19,
p=0.46; table 5). NIHR HTA-funded review reports had
a slightly lower mean relevance rating than publications
from the same studies publishing outside the HTA
Journal, which had a mean relevance rating of 5.62
(95% CI 5.38 to 5.87) (mean difference =0.16, 95% CI
−0.052 to 0.20, p=0.41; table 5).
NIHR HTA-funded original research reports had a
similar mean average relevance rating to NIHR HTA-
funded review reports with a mean rating of 5.54 (95% CI
5.34 to 5.74) compared with 5.46 (95% CI 5.32 to 5.60)
(mean difference=0.08, 95% CI −0.33 to 0.17, p=0.54).
Newsworthiness ratings in MORE
NIHR HTA-funded reports had a mean newsworthiness
rating of 4.75 (95% CI 4.60 to 4.86), which was similar
to that for non-NIHR HTA publications, which had a
mean newsworthiness rating of 4.70 (95% CI 4.69 to
4.71; mean difference=0.05, 95% CI −0.18 to 0.07,
p=0.402; table 3). NIHR HTA-funded publications pub-
lishing outside the HTA Journal had a higher average
mean newsworthiness rating than NIHR HTA reports,
with a rating of 4.93 (95% CI 4.73 to 5.13; mean differ-
ence=0.18, 95% CI −0.03 to 0.39, p=0.110; table 3).
The mean newsworthiness rating of NIHR
HTA-funded original research was 5.05 (95% CI 4.88 to
5.22), which was higher than that for non-NIHR HTA
original research publications, which had a mean news-
worthiness rating of 4.77 (95% CI 4.75 to 4.79; mean dif-
ference=0.28, 95% CI 0.03 to 0.53, p=0.03; table 4). The
mean newsworthiness rating for NIHR HTA-funded ori-
ginal research reports was similar to publications from
the same studies publishing outside the HTA Journal,
which had a mean average newsworthiness rating of 4.96
(95% CI 4.69 to 5.23; mean difference=0.09, 95% CI
−0.04 to 0.22, p=0.63; table 4).
The mean average newsworthiness rating of NIHR
HTA-funded review reports was 4.64 (95% CI 4.51 to 4.77),
which was similar to that for non-NIHR HTA-funded
reviews, which had a mean newsworthiness rating of 4.56
(95% CI 4.54 to 4.58; mean difference=0.08, 95% CI −0.05
to 0.21, p=0.24; table 5). The mean average newsworthi-
ness rating of NIHR HTA-funded review reports was lower
than that for the same NIHR HTA-funded reviews publish-
ing outside the HTA Journal, which had an average rating
of 4.87 (95% CI 4.56 to 5.17; mean difference=0.23, 95%
CI −0.11 to 0.57, p=0.21; table 5).
Table 2 Proportion of publications passing CAP and MORE ratings of relevance and newsworthiness
A: number (%)
NIHR HTA reports
2007–2012
B: number (%) Publications
2007–2012 from NIHR HTA
studies included in A
C: number (%) non-NIHR
HTA publications
2007–2012
All publications 286 118 190 391*
Number (%) passing CAP 194 (67.8) 68 (57.6) 20 194 (10.6)
Number (%) passing MORE in at
least one discipline
192 (67.1) 68 (57.6) 19 921 (10.5)
*Estimated on PubMed searches of the number of articles published in all read journals, 2007–2012 (excluding editorials, letters).
CAP, critical appraisal process; HTA, health technology assessment; MORE, McMaster Online Rating of Evidence; NIHR, National Institute
for Health Research.
Table 3 Mean average MORE clinical relevance and newsworthiness ratings across publication types
Number of
publications
Average relevance
(95% CI)
Average newsworthiness
(95% CI)
A: NIHR HTA reports 2007–2012 192 5.48 (5.36 to 5.59) 4.75 (4.60 to 4.86)
B: publications 2007—2012 from NIHR HTA
studies included in A
68 5.59 (5.42 to 5.75) 4.93 (4.73 to 5.13)
C: non-NIHR HTA publications 2007–2012 19 921 5.32 (5.31 to 5.33) 4.70 (4.69 to 4.71)
HTA,health technology assessment; NIHR,National Institute for Health Research.
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NIHR HTA original research reports had a higher
mean newsworthiness rating than NIHR HTA review
reports with a mean rating of 5.05 (95% CI 4.88 to 5.22)
compared with 4.64 (95% CI 4.51 to 4.77; mean differ-
ence=0.41, 95% CI 0.18 to 0.64, p=0.001).
DISCUSSION
This study found that hypothesis one was correct in part:
NIHR HTA studies reporting in HTA are rated as statis-
tically more clinically relevant than non-NIHR HTA arti-
cles publishing in the 120 high-impact journals included
by McMaster that pass CAP and MORE criteria.
However, ratings of newsworthiness were similar between
NIHR HTA studies reporting in HTA and non-NIHR
HTA publications. The second hypothesis was not
correct: ratings of clinical relevance and newsworthiness
were slightly lower for NIHR HTA reports in HTA than
publications from the same studies publishing outside
the journal, although these differences were not statistic-
ally signiﬁcant. NIHR HTA-funded original research
reports publishing in the HTA Journal were seen to be
more newsworthy than NIHR HTA-funded review
reports.
The study also found that the proportion of NIHR
HTA reports and other publications from NIHR
HTA-funded research passing initial screening criteria
was higher than that of non-NIHR HTA-funded publica-
tions (67.8% and 57.6%, compared with 10.6%, respect-
ively). This provides a further indication of the
comparatively high relevance and methodological rigour
of NIHR HTA-funded studies.
It is interesting to note that subsequent to the comple-
tion of this study, another project has been completed
that suggests that the assumptions behind the second
hypothesis were not correct. Chinnery et al assessed the
time to publication of projects funded by the NIHR
HTA Programme publishing in the HTA Journal and as
a journal article in the wider biomedical literature.11
They examined NIHR HTA projects with a planned sub-
mission date for the draft ﬁnal report on or before 9
December 2011 and reported that for primary research
the median time to publication in the HTA Journal was
faster than that in other non-HTA Journal publications
(26.5 and 35.5 months, respectively). This indicates that
further exploration of the clinical relevance and news-
worthiness of NIHR HTA reports compared with publi-
cations from the same studies publishing outside the
HTA Journal is warranted.
The strength of this study is that a rigorous, extensive
and independent approach to assessing the clinical rele-
vance and newsworthiness of funded research provided
by MORE was applied to NIHR HTA reports. However,
there were limitations to the study. First, the study used
internal research management data that were reliant on
funded research teams self-reporting their publications.
It is likely that the number of publications is under-
reported from NIHR HTA-funded studies and therefore
some NIHR HTA publications may be included in the
non-NIHR HTA publication dataset. Second, the study
compared NIHR HTA reports with non-NIHR HTA pub-
lications passing CAP and MORE. NIHR HTA-funded
studies are typically randomised controlled trials, system-
atic reviews or Technology Assessment Reports (which
identify, assess and synthesise research evidence from a
number of healthcare interventions, providing estimates
of the relative effectiveness and cost effectiveness of a
range of interventions). While subgroup analyses
matched original and review research, it could be more
effective to match publications by speciﬁc research
designs (eg, randomised controlled trials) or by similar
research funders. Third, the MORE scales were treated
Table 4 Mean average clinical relevance and newsworthiness ratings for original research by publication type
Number of
publications
Average relevance
(95% CI)
Average newsworthiness
(95% CI)
A: NIHR HTA reports 2007–2012 54 5.54 (5.34 to 5.74) 5.05 (4.88 to 5.22)
B: publications 2007—2012 from NIHR HTA
studies included in A
46 5.57 (5.36 to 5.78) 4.96 (4.69 to 5.23)
C: non-NIHR HTA publications 2007–2012 13 302 5.27 (5.26 to 5.29) 4.77 (4.75 to 4.79)
HTA,health technology assessment; NIHR,National Institute for Health Research.
Table 5 Mean average clinical relevance and newsworthiness ratings for review research by publication type
Number of
publications
Average relevance
(95% CI)
Average newsworthiness
(95% CI)
A: NIHR HTA reports 2007–2012 138 5.46 (5.32 to 5.60) 4.64 (4.51 to 4.77)
B: publications 2007—2012 from NIHR HTA
studies included in A
22 5.62 (5.38 to 5.87) 4.87 (4.56 to 5.17)
C: non-NIHR HTA publications 2007–2012 6619 5.41 (5.39 to 5.43) 4.56 (4.54 to 4.58)
HTA,health technology assessment; NIHR,National Institute for Health Research.
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as interval scales and therefore mean average ratings
were obtained. However, the data may be viewed as
ordinal, in which case median or mode averages would
be more appropriate. Fourth, raters contributing to
MORE do so on a voluntary basis and are likely to be
interested in evidence-based medicine, and therefore
may not be representative of all physicians. Fifth, no sub-
group analyses were conducted comparing articles from
NIHR HTA-funded studies published elsewhere prior to
publication in the HTA Journal and those published
after the HTA report. Conducting such subgroup ana-
lyses will provide interesting data on the impact of prior
publication on clinical relevance and newsworthiness
ratings.
Findings from this study contribute to the relatively
under-researched area of clinical relevance of health
research. Commissioning research topics in areas of low
relevance or in areas where the research evidence is
already known is a signiﬁcant contributing factor to
research waste.1 The MORE process has previously been
used to provide exploratory assessments of clinical
research by research type. McKinlay et al,6 for example,
reported that systematic reviews were rated signiﬁcantly
higher than original articles for relevance, but signiﬁ-
cantly lower for newsworthiness. This study reﬂected
these ﬁndings in part with NIHR HTA-funded original
research reports having a similar mean average rele-
vance rating to review reports, but a statistically higher
mean newsworthiness rating than review reports. The
lower newsworthiness rating of reviews is to be expected,
given that all the original articles which inform the
reviews are already published and thus are in the public
domain.6
The high clinical relevance rating of NIHR HTA
reports in relation to non-NIHR HTA-funded research
could be explained by the NIHR HTA Programme’s
identiﬁcation and prioritisation processes, which are spe-
ciﬁcally designed to ensure that important knowledge
gaps are identiﬁed. Topics are generated via a wide
range of stakeholder groups and sources, such as web
submissions, workshops with clinicians, academics and
patient and public representatives and outputs from the
James Lind Alliance Priority Setting Partnerships
(http://www.lindalliance.org/). These are screened by
specialists and an ‘overlap check’ is undertaken to
ensure that there is no duplication of current or com-
pleted research internally and externally, after which
topics are developed and prioritised by panels compris-
ing independent experts and patient and public contri-
butors. The higher clinical relevance rating of NIHR
HTA reports may therefore be attributed to the effective-
ness of these processes.
An additional factor may be due to the fact that the
NIHR HTA Programme has its own journal HTA, which
enables fuller descriptions of research than most other
journals allow. The accessibility and structure of the
reports in HTA may be a contributing factor to enhan-
cing assessments of relevance. However, all NIHR
HTA-funded studies are contractually obliged to report
in HTA regardless of the study outcome, resulting in a
high publication rate of funded studies.8 The HTA
Journal is therefore not as likely to be affected by publi-
cation bias as other health research literature, which
could therefore limit ratings of relevance and news-
worthiness when compared to other journals.
This study presents an exploratory assessment of clin-
ical relevance and newsworthiness by assessing the
outputs of one research funder. While this provides an
initial assessment of relevance and newsworthiness in
relation to highly rated publications in high-impact jour-
nals, further research is recommended to conﬁrm the
observations from the study. In particular, it is recom-
mended that further analyses are undertaken on outputs
that are matched by research type (eg, RCTs, systematic
reviews), research funders or speciﬁc journals. Further
research should also be conducted on assessing the
degree to which prior publication of NIHR HTA-funded
studies inﬂuences ratings of clinical relevance and news-
worthiness of HTA reports.
Commissioning or publishing research of low-clinical
relevance is an important factor in the waste of research
funds. It is recommended, therefore, that careful consid-
eration is given to clinical relevance when funding and
disseminating research.
CONCLUSION
Research commissioned by the NIHR HTA Programme
and published in the HTA Journal is more clinically rele-
vant than highly rated articles publishing in the 120
journals included in MORE. Reports publishing in the
HTA Journal had similar ratings of newsworthiness.
NIHR HTA-funded original research reports had a
similar mean average relevance rating to review reports,
but had a signiﬁcantly higher newsworthiness rating.
The clear and full accounts provided by the HTA
Journal and the rigorous topic identiﬁcation and priori-
tisation processes adopted by the NIHR HTA
Programme may be a factor in generating the high clin-
ical relevance rating. This study illustrates the import-
ance of considering clinical relevance when
commissioning and disseminating research in an effort
to minimise waste in research funding.
Acknowledgements The authors wish to thank the support of Carole Luke
and Beata Ferris who assisted in extracting publication records and PubMed
Identification numbers for National Institute for Health Research (NIHR)
Health Technology Assessment (HTA)-funded studies. They also thank Dr
Martin Ashton-Key for his assistance in commenting on an early draft of this
paper.
Contributors The study was designed by DW, RMi, RBH, ST and RMa. DW,
AY and EI extracted the data. EI conducted the data analyses. DW drafted the
manuscript. All authors have read and approved the final manuscript.
Funding This project was funded as part of the NETSCC Research on
Research Programme. The views and opinions expressed are those of the
authors and do not necessarily reflect those of the Department of Health and
of NETSCC.
6 Wright D, Young A, Iserman E, et al. BMJ Open 2014;4:e004556. doi:10.1136/bmjopen-2013-004556
Open Access
 group.bmj.com on August 20, 2014 - Published by bmjopen.bmj.comDownloaded from 
Competing interests DW, AY, RMa and ST are employees at the NIHR
Evaluation, Trials and Studies Coordinating Centre (NETSCC). RMi is
employed as the Head of NETSCC and has worked for NETSCC (and its
predecessor organisation) in senior roles intermittently since 1996. He was an
editor of the Health Technology Assessment journal (1997–2007) and a
founder editor for other journals in the new NIHR Journals Library (2011–12).
RBH and EI received payment to McMaster University from NETSCC for time
taken to analyse the MORE database.
Provenance and peer review Not commissioned; externally peer reviewed.
Data sharing statement No additional data are available.
Open Access This is an Open Access article distributed in accordance with
the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license,
which permits others to distribute, remix, adapt, build upon this work non-
commercially, and license their derivative works on different terms, provided
the original work is properly cited and the use is non-commercial. See: http://
creativecommons.org/licenses/by-nc/3.0/
REFERENCES
1. Chalmers I, Glasziou P. Avoidable waste in the production and
reporting of research evidence. Lancet 2009;374:86–9.
2. Gillum LA, Gouveia C, Dorsey ER, et al. NIH disease funding levels
and burden of disease. PLoS ONE 2011;6:e16837.
3. Tallon D, Chard J, Dieppe P. Relation between agendas of the
research community and the research consumer. Lancet
2000;355:2037–40.
4. McKibbon K, Wilczynski N, Haynes R. What do evidence-based
secondary journals tell us about the publication of clinically important
articles in primary healthcare journals? BMC Med 2004;2:33.
5. Lokker C, McKibbon KA, McKinlay RJ, et al. Prediction of citation
counts for clinical articles at two years using data available within
three weeks of publication: retrospective cohort study. BMJ
2008;336:655–7.
6. McKinlay RJ, Cotoi C, Wilczynski NL, et al. Systematic reviews and
original articles differ in relevance, novelty, and use in an
evidence-based service for physicians: PLUS project. J Clin
Epidemiol 2008;61:449–54.
7. Raftery J, Powell J. Health technology assessment in the UK. Lancet
2013;382:1278–85.
8. Turner S, Wright D, Maeso R, et al. Publication rate for funded
studies from a major UK health research funder: a cohort study. BMJ
Open 2013;3:e002521.
9. Hanney S, Buxton M, Green C, et al. An assessment of the impact
of the NHS Health Technology Assessment Programme. Health
Technol Assess 2007;11:iii–iv, ix–xi, 1–180.
10. Wilczynski N, Morgan D, Haynes RB, et al. The Hedges Team. An
overview of the design and methods for retrieving high-quality
studies for clinical care. BMC Med Inform Decis Mak 2005;5:20.
11. Chinnery F, Young A, Goodman J, et al. Time to publication for
NIHR HTA programme-funded research: a cohort study. BMJ Open
2013;3:e004121.
Wright D, Young A, Iserman E, et al. BMJ Open 2014;4:e004556. doi:10.1136/bmjopen-2013-004556 7
Open Access
 group.bmj.com on August 20, 2014 - Published by bmjopen.bmj.comDownloaded from 
doi: 10.1136/bmjopen-2013-004556
 2014 4: BMJ Open
 
D Wright, A Young, E Iserman, et al.
 
study
of NIHR HTA-funded research: a cohort 
The clinical relevance and newsworthiness
 http://bmjopen.bmj.com/content/4/5/e004556.full.html
Updated information and services can be found at: 
These include:
References
 http://bmjopen.bmj.com/content/4/5/e004556.full.html#ref-list-1
This article cites 10 articles, 3 of which can be accessed free at:
Open Access
non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/
terms, provided the original work is properly cited and the use is
work non-commercially, and license their derivative works on different 
license, which permits others to distribute, remix, adapt, build upon this
Creative Commons Attribution Non Commercial (CC BY-NC 3.0) 
This is an Open Access article distributed in accordance with the
service
Email alerting
the box at the top right corner of the online article.
Receive free email alerts when new articles cite this article. Sign up in
Collections
Topic
 (26 articles)Medical publishing and peer review   
 (224 articles)Evidence based practice   
 
Articles on similar topics can be found in the following collections
Notes
 http://group.bmj.com/group/rights-licensing/permissions
To request permissions go to:
 http://journals.bmj.com/cgi/reprintform
To order reprints go to:
 http://group.bmj.com/subscribe/
To subscribe to BMJ go to:
 group.bmj.com on August 20, 2014 - Published by bmjopen.bmj.comDownloaded from 
